{"id":1344294,"date":"2024-09-02T19:06:22","date_gmt":"2024-09-02T19:06:22","guid":{"rendered":"https:\/\/teknomers.com\/es\/agosto-de-2024-los-analistas-ajustan-la-calificacion-de-las-acciones-de-roche\/"},"modified":"2024-09-02T19:06:26","modified_gmt":"2024-09-02T19:06:26","slug":"agosto-de-2024-los-analistas-ajustan-la-calificacion-de-las-acciones-de-roche","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/agosto-de-2024-los-analistas-ajustan-la-calificacion-de-las-acciones-de-roche\/","title":{"rendered":"Agosto de 2024: los analistas ajustan la calificaci\u00f3n de las acciones de Roche"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<p>Lo que los expertos predicen para las acciones de Roche.<\/p>\n<div>\n<p>La acci\u00f3n de Roche fue analizada por 5 expertos en agosto de 2024.<\/p>\n<p>1 experto recomienda comprar acciones de Roche, 3 analistas califican las acciones de Roche como Mantener y 1 analista califica las acciones como Vender.<!-- sh_cad_2 --><\/p>\n<p>El precio objetivo medio de los expertos es de 277,00 CHF. Esto equivale a un descuento de 10,20 CHF sobre el precio SWX actual de las acciones de Roche de 287,20 CHF.<\/p>\n<p>La tendencia de calificaci\u00f3n de 6 meses es Mantener.<\/p>\n<table class=\"table table--content-right table--col-2-text-align-center\">\n<thead class=\"table__thead\">\n<tr class=\"table__tr\">\n<th class=\"table__th\">Analista<\/th>\n<th class=\"table__th\"\/>\n<th class=\"table__th\">Precio objetivo<\/th>\n<th class=\"table__th\">Precio objetivo de distancia<\/th>\n<th class=\"table__th\">Fecha<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"table__tbody\">\n<tr class=\"table__tr\">\n<td class=\"table__td\">Investigaci\u00f3n Bernstein<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--positive arrow--analysis\"\/><\/td>\n<td class=\"table__td\">340,00 francos suizos<\/td>\n<td class=\"table__td font-color-green\">18.38<\/td>\n<td class=\"table__td\">29 de agosto de 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Deutsche Bank AG<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">265,00 francos suizos<\/td>\n<td class=\"table__td font-color-red\">-7,73<\/td>\n<td class=\"table__td\">6 de agosto de 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Joh. Berenberg, Gossler &#038; Co. KG (Banco Berenberg)<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">290,00 francos suizos<\/td>\n<td class=\"table__td font-color-green\">0,97<\/td>\n<td class=\"table__td\">6 de agosto de 2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">JP Morgan Chase &#038; Co.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--negative arrow--analysis\"\/><\/td>\n<td class=\"table__td\">220,00 francos suizos<\/td>\n<td class=\"table__td font-color-red\">-23.40<\/td>\n<td class=\"table__td\">01\/08\/2024<\/td>\n<\/tr>\n<tr class=\"table__tr\">\n<td class=\"table__td\">Jefferies &#038; Company Inc.<\/td>\n<td class=\"table__td\"><span class=\"arrow arrow--analysis\"\/><\/td>\n<td class=\"table__td\">270,00 francos suizos<\/td>\n<td class=\"table__td font-color-red\">-5,99<\/td>\n<td class=\"table__td\">01\/08\/2024<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Equipo editorial finanzen.net<\/p>\n<\/div>\n<div id=\"\">\n<h2 class=\"headline headline--h4\">Productos de apalancamiento seleccionados en Roche<\/h2>\n<p>Con los knock-outs, los inversores especulativos pueden participar desproporcionadamente en los movimientos de precios. Simplemente seleccione la palanca que desee y le mostraremos los productos abiertos adecuados en Roche.<\/p>\n<p class=\"font-color-red display-none\" id=\"lvgCustomHandleInfo\">El apalancamiento debe estar entre 2 y 20<\/p>\n<p><span class=\"ad-hint ad-hint--right display-block\">Publicidad<\/span><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.finanzen.net\/nachricht\/aktien\/aktie-im-fokus-august-2024-so-haben-analysten-ihre-einstufung-der-roche-aktie-angepasst-13810646\" rel=\"nofollow noopener\" target=\"_blank\">ttn-es-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lo que los expertos predicen para las acciones de Roche. La acci\u00f3n de Roche fue analizada por 5<\/p>\n","protected":false},"author":1,"featured_media":1344295,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[668,23080,21785,4786,7275,246,36,55357],"class_list":["post-1344294","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finanzas","tag-acciones","tag-agosto","tag-ajustan","tag-analistas","tag-calificacion","tag-las","tag-los","tag-roche"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1344294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=1344294"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1344294\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/1344295"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=1344294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=1344294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=1344294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}